STAT3-IN-32

CAT: 0804-HY-164445Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-164445Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
STAT3-IN-32 (compound 2p) is an orally active, potent STAT3 dual phosphorylation inhibitor with an indole-containing tetra-aromatic heterocycle scaffold. STAT3-IN-32 exhibits STAT3 luciferase inhibition activity using HEK293T cells with an IC50 of 5.3 nM and ATP production inhibition activity using BxPC-3 cells with an IC50 of 4.2 nM. STAT3-IN-32 significantly blocks p-Tyr705 and p-Ser727 and causes the abrogation of the corresponding nuclear transcription and mitochondrial oxidative phosphorylation functions of STAT3 by targeting the STAT3 SH2 domain (KD=21.3 nM) . STAT3-IN-32 exhibits significant suppressive effects in a pancreatic cancer xenograft model[1].
CAS Number
[2591440-71-8]
UNSPSC
12352005
Target
STAT
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/stat3-in-32.html
Smiles
O=C(C(N1C)=CC2=C1C=C(OC3=NC=C(C4=NC(C5=CC=C(OC)C=C5)=NO4)N=C3)C=C2)N6CCN(CC7=CC=C(OCC(F)(F)F)C=C7)CC6
Molecular Formula
C36H32F3N7O5
Molecular Weight
699.68
References & Citations
[1]Peng He, et al. Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment. J Med Chem. 2022 Nov 24;65 (22) :15487-15511.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
STAT3

Related Products

CatalogName
HY-146666STAT3-IN-9
HY-163526-01STAT3-IN-26
HY-144870STAT3-IN-7
HY-179468STAT3-IN-49
HY-177990-01STAT3-IN-52
HY-161864STAT3-IN-29
HY-155808STAT3-IN-18
HY-123524-01STAT3-IN-4
HY-160496-01STAT3-IN-25
HY-100753-01STAT3-IN-1

Alternative Products

CatalogName
MBS8535722-01STAT3

Popular Products